MARAMAI SAMUELE | Professor page

Corallo, A.A., Maramai, S., Noli, C., Paolino, M., Brizzi, A., Ligresti, A., et al. (2026). Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 27(4) [10.3390/ijms27041716]. - view more
Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - view more
Cazzola, J., Talpo, F., Faravelli, G., Donati, C., Maramai, S., Saletti, M., et al. (2025). Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH-SY5Y-Derived Neurons. JOURNAL OF NEUROCHEMISTRY, 169(11) [10.1111/jnc.70280]. - view more
Maramai, S., Taddei, M., Castagnetti, A., Viciani, E., Koufi, F., Neri, I., et al. (2025). Drug enteric metabolism in gut microbiota-brain crosstalk. LIFE SCIENCES, 383 [10.1016/j.lfs.2025.124075]. - view more
Poggialini, F., Governa, P., Vagaggini, C., Maramai, S., Lamponi, S., Mugnaini, C., et al. (2025). Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 209 [10.1016/j.ejps.2025.107066]. - view more